(Reuters) - Gardasil is approved as a vaccination against four strains of the human papillomavirus, or HPV, including those considered responsible for roughly 70 percent of cervical cancer.
Merck said its new submission includes efficacy data showing some protection against additional cervical cancer-causing HPV types, and data on protection against vaginal and vulvar cancers.
Read more at Reuters.com Market News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment